KalVista Pharmaceuticals, Inc. - COM (KALV)

Historical Portfolio Holders from Q4 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
46.5 M
Holdings value Q1 2024
$552 M
Value change Q1 2024
+$118 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
125
Number of buys Q1 2024
77
Number of sells Q1 2024
-45
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
483497103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 46.5 M $552 M +$118 M $11.86 125
2023 Q4 36.5 M $447 M +$2.82 M $12.25 93
2023 Q3 36.1 M $348 M +$17.9 M $9.63 100
2023 Q2 34.4 M $310 M +$8.86 M $9.00 92
2023 Q1 33.7 M $265 M -$7.3 M $7.86 86
2022 Q4 33.8 M $229 M +$23.5 M $6.76 87
2022 Q3 25.5 M $371 M +$16.6 M $14.51 87
2022 Q2 24.2 M $238 M -$18.1 M $9.84 83
2022 Q1 23.9 M $352 M +$6.71 M $14.74 78
2021 Q4 23.8 M $315 M -$24.2 M $13.23 92
2021 Q3 23.4 M $408 M -$21.5 M $17.45 101
2021 Q2 24.2 M $581 M +$10.8 M $23.96 108
2021 Q1 23.5 M $604 M +$242 M $25.69 113
2020 Q4 14.6 M $278 M +$4.58 M $18.99 77
2020 Q3 15.6 M $197 M +$2.83 M $12.59 59
2020 Q2 16 M $194 M +$9.42 M $12.10 71
2020 Q1 15.6 M $119 M +$17.3 M $7.65 66
2019 Q4 13.7 M $244 M +$13.4 M $17.81 70
2019 Q3 13.2 M $153 M -$34 M $11.60 73
2019 Q2 14.8 M $327 M +$6.26 M $22.15 72
2019 Q1 13.9 M $398 M +$23.8 M $28.62 67
2018 Q4 13 M $256 M +$10.7 M $19.75 55
2018 Q3 12.3 M $271 M +$111 M $22.11 46
2018 Q2 6.32 M $51.3 M -$1.58 M $8.12 24
2018 Q1 6.5 M $61.6 M +$134 K $9.48 22
2017 Q4 6.48 M $63.2 M -$3 M $9.75 22
2017 Q3 7.72 M $52.2 M +$2.31 M $6.73 15
2017 Q2 7.37 M $54.1 M -$1.77 M $7.36 16
2017 Q1 7.59 M $59.2 M +$2.02 M $7.81 17
2016 Q4 7.33 M $51.5 M +$47 M $7.07 18